Search Engine Marketing
A Blogroll Update
Tuesday, November 17th, 2009
I’ve gone through the blogroll, clearing out inactive sites and adding new ones. So welcome to Med-Chemist , Chemical Crystallinity , Synthetic Nature ,
Read the full story
NYC Health Department buys Google Ads
Thursday, June 4th, 2009
According to the Wall Street Journal, the New York City Health Department has bought Google Ads in order to reach the citizens in their city. In ads that began running Monday, the NYC Health department bought search words that had to do with the H1N1 virus in order to reach the citizens of the city who are looking for the right information. The search terms have worked, as each day around 1,000
Read the full story
Uh, Oh! Will FDA Cite this “One-Click Rule” Twitter Post by AZ as Violative?
Thursday, May 28th, 2009
Remember the 14 Notice of Violation (NOV) letters that FDA sent to 14 drug companies citing their Adwords — paid search engine ads — for violating FDA regulations? At issue was (and still is) the so-called “One-Click Rule,” which states that an online Rx drug ad can mention the brand name and the benefits (indications) without including all or any of the major side effect effects (fair balance) as long as the fair balance is just one click away (ie, on the landing page). See ” The ‘One-Click Rule’: Rant or No Rant
Read the full story
Navigating Regulatory Issues on the Web
Wednesday, May 27th, 2009
On April 3, 2009, the FDA’s Division of Drug Marketing, Advertising and Communications (DDMAC) posted to its website a list of 14 untitled letters issued to pharmaceutical companies during the last week of March. All of the letters related to materials known as “sponsored links” on various internet search engines (e.g., Google). These links represent [...]
Read the full story
Warning Letter Quarterly Update, Last Quarter 2008, First Quarter 2009, Part 1
Sunday, May 17th, 2009
It is always a good idea to review the content of Warning and untitled letters to learn from the lessons being taught be DDMAC with respect to communications that promote the marketing of pharmaceutical, biotech and device products. However, I have been behind on reporting on the Warning and Untitled Letter updates from DDMAC and my last report was for the third quarter of 2008
Read the full story
Online search and Pharma companies
Monday, April 27th, 2009
The FDA has recently changed the policies on search engine marketing. Companies can only buy sponsored search terms if they can contain a fair and balanced claim.
Read the full story
Search Ad Warnings Leave Pharma in Online Void
Tuesday, April 14th, 2009
After last week’s flurry of FDA warning letters directed at companies marketing through search ads, industry is left wondering what can be done be done to target patients online?
Posted in: Search Engine Marketing | 0 Comments »
Read the full story
Pharma Companies Hit With Warnings for Search Marketing
Tuesday, April 7th, 2009
FDA is cracking down on content in search engine advertisements. The argument is that there is a serious deficiency of risk information in the tiny link ads that appear on search ads. With pharma already wary of marketing online, will FDA’s tactic hurt future Web campaigns?
Posted in: Search Engine Marketing | 0 Comments »
Read the full story
FDA cracks down on search-engine ads
Tuesday, April 7th, 2009
According to FiercePharma.com, fourteen companies, including Biogen Idec, Pfizer, Sanofi-Aventis, GlaxoSmithKline, Roche received warning letters from the FDA about “sponsored links” within Google’s search engine. The links go to the advertised drug’s website where plenty of information is available
Read the full story
Business Week – Drug Marketing
Business Week – Pharma Marketing
Cafe Pharma
Clinical Trials.gov
FDA on Twitter
Pharma Live
Pharma Voice